Phase II Trial for RA Drug Begins

Links shared publicly online about this topic.

  • 825
    total visits

Phase II Trial for RA Drug Begins

hcplive.com

A phase II clinical study began for Galapagos NV%u2019s drug candidate GLPG0259, a novel drug being developed for rheumatoid arthritis.

View full resource at hcplive.com

Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Drug

  • Share

Most Recently Shared on October 4, 2010 at 9:29 pm By:

Southampton scientists begin Phase II patient trial for new asthma treatment

physorg.com — “Scientists from the University of Southampton and Synairgen Research Ltd, a respiratory drug development company spun out from the University, have begun a Phase II study into the effectiveness of the drug interferon beta for asthma patients.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on April 8, 2010 at 5:24 pm By:

monajauharRD Mona Jauhar Health Professional

Southampton scientists begin Phase II patient trial for new asthma treatment: Scientists from the University of So... http://bit.ly/cI9GIt

2 years ago...

Southampton scientists begin Phase II patient trial for new asthma treatment

physorg.com — “Scientists from the University of Southampton and Synairgen Research Ltd, a respiratory drug development company spun out from the University, have begun a Phase II study into the effectiveness of the drug interferon beta for asthma patients.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on April 8, 2010 at 5:01 pm By:

physorg_health PhysOrg Health News Health News

Southampton scientists begin Phase II patient trial for new asthma treatment http://tw.physorg.com/189949188

2 years ago...

Phase II--Islet Regeneration - TuDiabetes

tudiabetes.com — “From www.diabetesincontrol.com Phase II Begins for a New Islet Regeneration Treatment Exsulin Corporation announces next phase II trial of novel islet regeneration treatment in Type 1 diabetes. Leading diabetes research centers collaborate on new trial designed to further evaluate regeneration treatment for people with Type 1 diabetes. Exsulin Corporation announces the start of a phase II human clinical trial of Exsulin(TM), a peptide drug product aimed at restoring insulin production in peopView full resource at tudiabetes.com

  • View Related
  • Share

Most Recently Shared on September 16, 2009 at 7:02 am By:

tudiabetes a diabetes community Support

Type 1 diabetes: Phase II--Islet Regeneration: From www.diabetesincontrol.com Phase II Begins .. http://bit.ly/4BcX76

3 years ago...

Advertisement